A Study to Evaluate the Efficacy and Safety of AK120 in Subjects With Moderate to Severe Atopic Dermatitis

PHASE2RecruitingINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

July 8, 2024

Primary Completion Date

November 17, 2025

Study Completion Date

November 17, 2025

Conditions
Atopic Dermatitis
Interventions
DRUG

AK120 300mg Q2W (JAK inhibitor users need to double the initial dose)

AK120 300mg Q2W SC until week 14(JAK inhibitor users need to receive a first dose of 600mg SC)

Trial Locations (50)

Unknown

RECRUITING

Beijing Luhe Hospital Affiliated to Capital Medical University, Beijing

RECRUITING

Peking University Third Hospital, Beijing

RECRUITING

Xiyuan Hospital of CACMS, Beijing

RECRUITING

The First Affiliated Hospital of Fujian Medical University, Fuzhou

NOT_YET_RECRUITING

The Second Affiliated Hospital of Xiamen Medical College, Xiamen

RECRUITING

The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou

RECRUITING

Guangdong Provincial Dermatology Hospital, Guangzhou

RECRUITING

Guangdong Provincial People's Hospital, Guangzhou

RECRUITING

Second people's Hospital of Shenzhen, Shenzhen

RECRUITING

Shenzhen Hospital of University of Hong Kong, Shenzhen

RECRUITING

Liuzhou People's Hospital, Liuzhou

RECRUITING

Cangzhou People's Hospital, Cangzhou

RECRUITING

Affiliated Hospital of Chengde Medical University, Chengde

RECRUITING

Shijiazhuang Hospital of Traditional Chinese Medicine, Shijiazhuang

RECRUITING

The First Hospital of Hebei Medical University, Shijiazhuang

RECRUITING

People Hospital of Xingtai, Xingtai

RECRUITING

The Second Affiliated Hospital of Xingtai Medical College, Xingtai

RECRUITING

Anyang District Hospital, Anyang

RECRUITING

The Second Affiliated Hospital of Henan University of Science and Technology, Luoyang

RECRUITING

Sanmenxia Central Hospital, Sanmenxia

RECRUITING

Jingzhou Central Hospital, Jingzhou

RECRUITING

Renmin Hospital of Wuhan University, Wuhan

RECRUITING

Wuhan No.1 Hospital, Wuhan

RECRUITING

Changde First People's Hospital, Changde

RECRUITING

XiangYa Hospital CentralSouth University, Changsha

RECRUITING

Yueyang Central Hospital, Yueyang

RECRUITING

The Affiliated Hospital of Inner Mongolia Medical College, Hohhot

RECRUITING

Affiliated Hospital of Nantong University, Nantong

RECRUITING

Wuxi People's Hospital, Wuxi

RECRUITING

Affiliated Hospital of Jiangsu University, Zhenjiang

RECRUITING

The Affiliated Hospital of Yanbian University Yanbian Hospital, Yanbian

RECRUITING

Qilu Hospital of Shandong University, Jinan

RECRUITING

Shandong First Medical University Affiliated Dermatology Hospital, Jinan

RECRUITING

Yantai Yuhuangding Hospital, Yantai

RECRUITING

Shanghai Skin Disease Hospital, Shanghai

RECRUITING

Shanghai Yueyang Integrated Traditional Chinese Medicine and Western Medicine Hospital, Shanghai

RECRUITING

Taiyuan Central Hospital, Taiyuan

RECRUITING

Sichuan Provincial People's Hospital, Chengdu

RECRUITING

The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin

RECRUITING

Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin

RECRUITING

Xinjiang Uygur Municipal People's Hospital, Ürümqi

RECRUITING

The First Affiliated Hospital of Kunming Medical University, Kunming

RECRUITING

Qujing No.1 Hospital, Qujing

RECRUITING

Affiliated Hangzhou First People's Hospital, Hangzhou

RECRUITING

Hangzhou Third People's Hospital, Hangzhou

RECRUITING

The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou

RECRUITING

Jiaxing Second Hospital, Jiaxing

RECRUITING

The First Hospital of Jiaxing, Jiaxing

RECRUITING

Ningbo No.2 Hospital, Ningbo

RECRUITING

Taizhou Central Hospital, Taizhou

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Akeso

INDUSTRY